Navigation Links
InterMune Names Jonathan A. Leff, M.D., as Executive Vice President of Research and Development
Date:2/9/2012

ylvania School of Medicine. 

About InterMune
InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases.  In pulmonology, we are focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.  Pirfenidone, the only medicine approved for IPF anywhere in the world, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial in the United States.  Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the trade name Pirespa®.  InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases.  For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements
This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation, the statements related to the achievement of InterMune's Vision 2015 Strategic Plan, the growth of our scientific endeavors, the expansion of our product portfolio and InterMune's clinical development plans.  All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements.

Other factors that
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. InterMune Reports Preliminary Fourth Quarter 2011 EsbrietĀ® (pirfenidone) Revenue and Other Recent Business Highlights
2. InterMune Appoints Angus C. Russell to Board of Directors
3. InterMune to Release Third Quarter Financial Results on November 3
4. InterMune Announces Launch of EsbrietĀ® (pirfenidone) in Germany
5. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
6. InterMune Receives European Union Approval for EsbrietĀ® (pirfenidone)
7. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
8. InterMune to Present at J.P. Morgan Healthcare Conference
9. InterMune Reports Third Quarter 2010 Financial Results
10. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
11. InterMune to Release Second Quarter Financial Results on July 27
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... ALTOS, Calif. , Dec. 18, 2014 /PRNewswire/ ... a new generation of equipment for the testing ... the release of the new Luminary™ Profiler, the ... accurate light-based measurement in a cost-effective, portable unit. ... meet the specific needs of the cannabis industry, ...
(Date:12/19/2014)... SAN DIEGO , Dec. 18, 2014  RESMED INC. ... report its second quarter of fiscal year 2015 results on ... market close. A press release with ResMed,s results will be ... will host a webcast to discuss operating results and future ... at 1:30 p.m. US Pacific Time and the live webcast ...
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
Breaking Medicine Technology:Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2ResMed To Announce Second Quarter 2015 Results 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5
... ORLEANS, June 16 Cardinal Health, a,global provider ... and,productivity of health care, today announced that it ... (PET),radiopharmaceuticals for clinical trials., The company,s new ... at the Society of Nuclear Medicine,s (SNM) 55th ...
... the efficacy of RESPeRATE while highlighting ... BERLIN and NEW YORK, June 16 European Society ... Ltd., a medical device,company publicly traded on the Tel-Aviv ... studies and analysis highlighting RESPeRATE,-- the only medical device ...
Cached Medicine Technology:Cardinal Health Expands PET Nuclear Pharmacy Services to Support Clinical Drug Trials 2Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 2Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 3Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies 4
(Date:12/19/2014)... News) -- The intestinal bacteria that cause inflammatory bowel ... be inherited, researchers report. The findings, published recently ... in efforts to prevent the disease and treat the ... authors added. "The intestinal bacteria, or ,gut microbiome, ... a big impact on your health for the rest ...
(Date:12/19/2014)... Potentially illness-causing E. coli bacteria were found on nearly ... a new study. Researchers checked cilantro, basil and ... in Los Angeles and Orange counties in California, and ... tested, 24 percent were positive for E. coli. One ... Both types of bacteria can cause sometimes serious ...
(Date:12/19/2014)... of bacteria called biofilms can be found on most colon ... researchers said these biofilms were especially prevalent on the right ... may represent an increased likelihood of colon cancer and could ... the disease, the researchers said. Like tooth plaque and ... layer of cells lining the colon, according to background information ...
(Date:12/19/2014)... -- Older adults who have lost all their teeth have ... still have at least some of their teeth, a new ... could provide an early warning of increased risk of physical ... However, the findings don,t prove that tooth loss causes ... than 3,100 participants 60 and older. People with no remaining ...
(Date:12/19/2014)... CA (PRWEB) December 19, 2014 Diet ... to date, current approach to weight loss ... medical understanding. The professionals at the company understand that ... the side effects of eliminating carbohydrates and sugars from ... and tempted to abandon their weight loss goals. ...
Breaking Medicine News(10 mins):Health News:Crohn's, Colitis May Have Genetic Underpinnings, Study Finds 2Health News:E. Coli Germs Found on Farmers Market Herbs 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Loss of Teeth Linked to Physical, Mental Decline in Study 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 2Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 3Health News:Diet Doc Incorporates Appetite Zap into their Already Impressive Collection of Diet Products to Jump Start the Metabolism and Burn Fat 4X Faster 4
... Minn. New research links ,silent strokes, or small spots of ... adults to memory loss in the elderly. The study is published ... the medical journal of the American Academy of Neurology. ... elderly is that it examines silent strokes and hippocampal shrinkage simultaneously," ...
... Dennis Thompson HealthDay Reporter , WEDNESDAY, Dec. 28 ... but old-fashioned letter-writing may have a more beneficial lasting effect ... war zones, most in Iraq, researchers found that letters from ... onto paper or typed into an email -- served as ...
... WEDNESDAY, Dec. 28 (HealthDay News) -- Instant communication may be ... beneficial lasting effect on recipients. In a study involving ... that letters from home -- just a few words from ... -- served as an inoculation against one of war,s most ...
... -- Regular beer and even some brands of beer labeled ... for people with celiac disease, a new study says. ... gluten called hordein. However, some beer companies contend that the ... levels, according to a release from the Journal of ...
... DALLAS Dec. 22, 2011 A UT Southwestern Medical ... found that multidrug-resistant tuberculosis (TB) is more likely caused in ... is widely believed. If the study published in The ... future investigations, it may lead to better ways to treat ...
... Dec. 27 (HealthDay News) -- A new test measuring levels of ... really having a heart attack earlier than is currently possible. ... when the heart muscle has been damaged such as during a ... more troponin there will be in the blood. Existing tests measure ...
Cached Medicine News:Health News:In High-Tech Age, the Good Old Letter Still Holds Sway 2Health News:In High-Tech Age, the Good Old Letter Still Holds Sway 3Health News:In the Age of Email, the Good, Old Letter Still Holds Sway 2Health News:In the Age of Email, the Good, Old Letter Still Holds Sway 3Health News:UT Southwestern research suggests new way to ensure effectiveness of TB treatment 2Health News:New Blood Test May Rule Out Heart Attacks More Quickly 2
Bax detection system is a fast and accurate test for screening food and environmental samples by breaking them down to genetic level, using the power of the polymerase chain reaction (PCR) to detect ...
... SkanWasher 300 is an ... designed to give reliable, ... cross-contamination between wells, and ... to plate. The washer ...
A versatile plate washer and/or dispenser that aspirates from the top down without immersing the aspirating tubes in the well, ensuring overflow protection. 5 programmable protocols....
The 96 PW is an intelligent full microplate washer with a 96 needle wash head washing all wells simultaneously. This instrument gives high throughput and outstanding washing efficiency....
Medicine Products: